AMNEAL PHARMACEUTICALS

7,1900

22-мая-25 13:45:00

15 мин. задержка

Акции

-0,0800

-1,10%

Сегодняшний диапазон

7,1400 - 7,3000

ISIN

N/A

Источник

NASDAQ

Amneal Receives U.S. FDA Approval for Brekiya® (dihydroergotamine mesylate) injection for the Acute Treatment of Migraine and Cluster Headaches in Adults

15 май 2025 05:00:00 Источник Nasdaq GlobeNewswire
Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (BFS) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.

08 май 2025 04:00:00 Источник Nasdaq GlobeNewswire
Amneal Announces Complete Response Resubmission for IPX203 New Drug Application

08 фев 2024 13:05:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.